Venmax Drugs And Pharmaceuticals Ltd Share Price

₹27.30 -0.44 (-1.59%) BSE
as updated on 26-Dec-2025 16:59 | Sector - Healthcare

Day Range

  • Day's Low:27.30
  • Day's High:29.07

  • 52 Week Low16.38
  • 52 Week High36.96

Venmax Drugs And Pharmaceuticals Ltd's key Fundamentals

Market Cap ₹20 Cr.
P/E Ratio 59.3
TTM EPS 0.5
P/B Ratio 2.57
ROE -0.56
Debt to Equity -0.08
Face Value 10
BVPS 10.8
3 Year Sales Growth 0.00%

Venmax Drugs And Pharmaceuticals Ltd's Share Price Returns

1 Day -1.59%
1 Week -4.90%
1 Month -8.70%
3 Months 23.30%
6 Months 11.20%
1 Years 66.70%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Financial Ratio Analysis

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

Check our DeciZen before investing

Check Stock Quality
Check Stock Valuation
Check Price Trend

Venmax Drugs And Pharmaceuticals Ltd Shareholding Pattern

Promoters

(23.13%)

Institutions

(0.00%)

Non-Institutions

(76.87%)

Pledged shares as % of Promoter's holding (%)

(0.00%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Balance Sheet

(All Figures are in Crores.)

Profit And Loss

(All Figures in Cr. Adjusted EPS in Rs.)

Cash Flow

(All Figures are in Crores.)

About Venmax Drugs And Pharmaceuticals Ltd

Venmax Drugs and Pharmaceuticals is a public limited company incorporated under Companies Act, 1956 and domiciled in India. The company was initially incorporated as private limited company under the name and style of ‘Yenkay Medico Private Limited’, on September 28, 1998. The company thereafter changed its name to ‘Yenkey Drugs & Pharmaceuticals Private Limited’ on January 18, 1995. The company has become a public limited company on February 3, 1995 with ‘Yenkey Drugs & Pharmaceuticals Ltd’. Finally, the company has changed its name to ‘Venmax Drugs & Pharmaceuticals Ltd’ on April 13, 2009.

The company is engaged in the business of pharmaceutical products, drug intermediates, and Active Pharmaceutical Ingredients (APIs). It is currently developing oncology products in its R&D division. The company is planning to establish a cGMP-compliant manufacturing unit in the Pharma Cluster at Hyderabad to meet export demand.

Business area of the company

Venmax Drugs and Pharmaceuticals is engaged in the business of pharmaceutical products, drug intermediates, and active pharmaceutical ingredients.

Read More Read Less
Read More Read Less

Investment related blogs

Day Range

  • Day's Low: 27.30
  • Day's High: 29.07

  • 52 Week Low16.38
  • 52 Week High36.96

Venmax Drugs And Pharmaceuticals Ltd's key Fundamentals

Market Cap ₹20 Cr.
P/E Ratio 59.3
TTM EPS 0.5
P/B Ratio 2.57
ROE -0.56
Debt to Equity -0.08
Face Value 10
BVPS 10.8
3 Year Sales Growth 0.00%

Venmax Drugs And Pharmaceuticals Ltd's Share Price Returns

1 Day -1.59%
1 Week -4.90%
1 Month -8.70%
3 Months 23.30%
6 Months 11.20%
1 Years 66.70%
3 Years 0.00%
5 Years 0.00%
10 Years 0%

Investment related blogs

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×